Navigation Links
Examination of lymph nodes provides more accurate breast cancer prognosis
Date:7/29/2013

After a breast cancer operation, the removed tumour is always examined, as its subtype can provide an indication of how aggressive the disease is. The patient's lymph nodes are not analysed in the same way. Yet the breast tumour can sometimes appear to be of a less aggressive type while the subtype in the lymph nodes gives a different and more worrying picture.

In these cases, it is the lymph nodes that provide the correct prognosis, according to new research at Lund University in Sweden. An analysis of the proliferation, hormone receptor status and HER2 status of the lymph nodes would in many cases show a significantly more accurate picture of the risk of metastases, i.e. a recurrence of the disease and its spreading to other organs.

"It would be easy to add such an analysis. It does not require any expensive specialist technology, but only an extension of the normal, routine pathology work", says Lisa Rydn, a consultant surgeon and researcher at Lund University.

The study covers 500 women in the early stages of breast cancer who underwent surgery in Lund or Helsingborg. Early-stage breast cancer is when the cancer has not yet spread to other organs. However, in approximately one third of all the women who underwent surgery for early-stage breast cancer, there were traces of the tumour in the lymph nodes, which can provide important additional information.

"Sometimes the molecular study showed the same subtype in the breast tissue and in the lymph nodes. But sometimes the types were different. And when we investigated the outcomes for the women 10 years later, the prognosis followed the subtype that was present in the lymph nodes and not the one in the breast", says Lisa Rydn.

Thus when doctors only examine the breast tissue, there is a risk that the tumour will be found to be of a low-risk type, which affects decisions on further treatment. The lymph nodes may meanwhile show signs of a more aggressive form of tumour, but that is never discovered.

"If, on the other hand, we start routinely analysing the lymph nodes as well, we can treat women in such cases with additional cytostatic and targeted drugs after their operation. This could prevent later recurrence of the disease" thinks Lisa Rydn.

A fairly small proportion of the patients in the study showed a difference in tumour type between the breast tissue and the lymph nodes. But since breast cancer is such a common disease, the number of patients affected nationally and globally will still be considerable and, for them, the difference can be that between life and death, the Lund researcher points out.


'/>"/>

Contact: Lisa Rydén
lisa.ryden@med.lu.se
46-706-720-923
Lund University
Source:Eurekalert

Related medicine news :

1. North American Seminars Receives NY State Approval for a New Physical Therapy Online Continuing Education Course, Examination and Treatment of the SI Joint
2. North American Seminars Introduces a New Online Continuing Education Course for Physical Therapists, Examination and Treatment of the Hip Joint
3. North American Seminars Introduces Vestibular Rehabilitation - Examination and Treatment, a New Physical Therapy Online Continuing Education Course
4. North American Seminars Introduces a New Online Continuing Education Course for Physical Therapists, Examination and Treatment of the SI Joint
5. Sharing examination questions threatens trust in medical profession
6. Report offers an in-depth examination of health centers role in family planning
7. Decision support system translates into high percentage of positive chest CT examinations
8. HIV-associated lymphoma survival has not improved during the antiretroviral therapy era
9. North Shore-LIJ Health System's Feinstein Institute to Receive $250,000 Grant from Lymphoma Research Foundation Grant to support research of Chronic Lymphocytic Leukemia
10. Innovative Technique Seeks to Prevent Lymphedema in Breast Cancer Patients
11. Radioimmunotherapy deemed safe and effective for lymphoma patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... The National Campaign to Prevent Teen ... to Contraception for Women Servicemembers and Dependents Act of 2017. The bill, introduced ... to ensure that all members of the Armed Forces receive high quality education ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of ... rating of “A” and its outlook as “stable.” At the same time, the ratings ... fallen in recent years, dip below “capital adequacy” thresholds required for its strong rating. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... or hERG liability could substantially improve drug safety and minimize the cost of ... for validating ion channel inhibition using cell lines and for cardiac toxicity using ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... for the North East region. Côté has 20+ years of experience within the ... Phytomer, Côté worked with an array of high-end cosmetic brands, retail brands and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017 The Global ... Forecast to 2022 report has covered and analysed the potential ... information on market size, shares and growth factors. The report ... challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major ...
(Date:4/19/2017)... April 19, 2017 ... immune response in pets such as canine, avian ... of various types such as Attenuated Live Vaccines, ... DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines ... or bacteria, which have been weakend under laboratory ...
Breaking Medicine Technology: